The studies above identify common characteristics of resistant phenotypes in melanoma and other cancers, which include dedifferentiation, mitogenic rewiring, chromatin restructuring and inflammatory signalling especially via IFN pathway enrichment. The gene discussed is IFNA1; the disease is melanoma.